Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Procedural Pain Associated With Turning in Patients With Mechanical Ventilation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Subjects must meet all the following criteria:~1. Patients that will come with a minimum 24-hour schedule of mechanical ventilation (MV)~2. Patients men and women\> 18 years and \<85 years~3. Patients speak and / or understand the Castilian / Catalan~4. Patients with hemodynamic and respiratory stability enough, that allows mobilization procedure turn.~5. Patients who have a carer / guardian giving consent to participate in the study~Exclusion Criteria:~The subjects presenting one or more of the following criteria are NOT eligible to participate in this study:~1. Patients with known hypersensitivity to fentanyl and muscle relaxants~2. Patients who are receiving a neuromuscular blocking Neurocritical~3. Patients serious (TCE and / or other severe neurological injury (Glasgow \<8), increased intracranial pressure, peripheral neuropathy, quadriplegia)~4. Patients with brain death or vegetative state~5. Patients who have received some extra supplement opioids (morphine, Fentanest) bolus within 4 hours prior to the study.~6. Collaboration in the 30 days prior to any study either experimental drugs or devices.~7. Patients that potentially present alterations in the ability to understand when they are aware to understand the purpose of the study and to give informed consent in writing.~8. Patients undergoing treatment with Monoamine Oxidase Inhibitors~9. Women who are pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo Treatment: A sterile sodium chloride injection 0.9% 10 ml
- Fentanest (Type: EXPERIMENTAL): For this study Fentanest doses were adjusted based on published guidelines from the values recommended media to a whole number and differentiating two groups of patients (multiple trauma / surgical or medical) The maximum dose is 100 mcg Fentanest. The multiple trauma patients / surgical 1.5 mcg / kg and in medical patients 1.0 mcg / kg were given a single bolus Fentanest / Placebo by type of patient (surgical / multiple trauma or physician) 5 'before turning mobilization with personal hygiene.~The bolus is given slowly (30'') intravenously, to be preferred by a peripheral without vasoactive drugs (only with fluid therapy).~Pharmaceutical form:~Sterile solution for injection. Each mL of injectable solution contains the equivalent of 0.05 mg of Fentanest; Excipients: sodium chloride and water for injection.

Based on this trial design, predict the completion outcome and termination type (if applicable).